{
  "trial_id": "NCT00473460",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Male or female out-patients >/= 45 years",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Subjects suffering from chronic bronchitis",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "FEV1</= 70% and FEV1/FVC </= 70% predicted from age, height and sex",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "No documented episode of AECB (requiring treatment) within 6 weeks of randomization",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Sputum production on most days, even when exacerbation free",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Subjects presented with at least two documented (i.e. requiring antibiotics and/or systemic steroid administration) acute exacerbation episodes during the last 12 months",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "If receiving chronic therapy with inhaled long acting bronchodilators and/or inhaled or systemic steroids, the treatment must have remained stable for the preceding 6 weeks prior to screening",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Smoking history of at least 20 pack-years",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Subjects willing and able to give fully informed written consent",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Randomly to one of the following treatment groups at the second visit.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Receives moxifloxacin orally once daily for five days.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Matching placebo once daily for five days.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Subjects with contra-indications to moxifloxacin",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Known bronchial carcinoma, pulmonary tuberculosis, cystic fibrosis, documented chronic bronchial asthma or diffuse bronchiectasis",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Subjects who are actively participating in intensive pulmonary rehabilitation programs",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Subjects with a known history of chronic colonization of pathogenic organisms resistant to moxifloxacin, e.g. Pseudomonas spp, MRSA",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "No systemic or inhaled antibiotic therapy during the 6 weeks prior to screening and any long term antibiotic usage",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Subjects requiring home ventilatory support for COPD and those who have a tracheostomy in situ (subjects requiring home/potable oxygen therapy or CPAP for sleep apnea can be included)",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "The patient has chronic bronchitis, sputum production on most days, and a smoking history of at least 20 pack-years. However, he requires home ventilatory support for COPD.",
  "_meta": {
    "topic_id": "75",
    "trial_id": "NCT00473460",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}